Based on the above evidence, we speculated that CHST11 may regulate TME in HCC by promoting the infiltration of Tregs, thereby causing tumor cells to evade host immunity, further leading to tumor development and resulting in poor clinical outcomes. This evidence concerns the gene CHST11 and hepatocellular carcinoma.